These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26416052)

  • 21. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
    Huang C; Bei L; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum nitric oxide levels in patients with benign and malignant biliary disease: a prospective single center study.
    Beyazit Y; Sayilir A; Koklu S; Torun S; Suvak B; Tas A; Purnak T; Kalkan IH; Yesil Y; Ibis M
    J Clin Gastroenterol; 2013 Mar; 47(3):258-63. PubMed ID: 23059408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic value of serological tumor marker tests in patients with ovarian cancer].
    Kobayashi H; Sumimoto K; Terao T; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1501-6. PubMed ID: 2573640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of bile cytology in the diagnostic management of patients with biliary tract obstruction.
    Cobb CJ; Floyd WN
    Acta Cytol; 1985; 29(2):93-100. PubMed ID: 2984868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer.
    Liu F; Du F; Chen X
    World J Surg Oncol; 2014 Nov; 12():333. PubMed ID: 25381564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of serum receptor-binding cancer antigen (RCAS1) in pancreatic cancer and benign pancreatobiliary diseases.
    Ozkan H; Akar T; Köklü S; Coban S
    Pancreatology; 2006; 6(4):268-72. PubMed ID: 16636598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile levels of carcino-embryonic antigen in patients with hepatopancreatobiliary disease.
    Buffet C; Fourré C; Altman C; Prat F; Fritsch J; Choury A; Briantais MJ; Desgrez A; Etienne JP
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):131-4. PubMed ID: 8723416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
    Brockmann J; Emparan C; Hernandez CA; Sulkowski U; Dietl KH; Menzel J; Wolters H; Glodny B; Senninger N
    Anticancer Res; 2000; 20(6D):4941-7. PubMed ID: 11326643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma.
    Wang Z; Tian YP
    Mol Clin Oncol; 2014 Mar; 2(2):265-268. PubMed ID: 24649344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urine diacetylspermine as a novel tumour maker for pancreatobiliary carcinomas.
    Yamaguchi K; Nakamura M; Shirahane K; Konomi H; Torata N; Hamasaki N; Kawakita M; Tanaka M
    Dig Liver Dis; 2005 Mar; 37(3):190-4. PubMed ID: 15888284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis of ovarian tumor by measuring tumor markers].
    Fukatsu T; Nakashima N; Takeuchi J
    Rinsho Byori; 1992 Feb; 40(2):133-8. PubMed ID: 1583785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of carcinoembryonic antigen, carbohydrate antigen 19-9 and cytology of bile in diagnosis of biliary and pancreatic cancer].
    Matsuda M; Shimizu Y; Chikamatsu E; Takayanagi K; Ishigure H; Murakami S; Odani K
    Nihon Geka Gakkai Zasshi; 1991 Jun; 92(6):716-21. PubMed ID: 1886576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibronectin in human bile fluid for diagnosis of malignant biliary diseases.
    Körner T; Kropf J; Hackler R; Brenzel A; Gressner AM
    Hepatology; 1996 Mar; 23(3):423-8. PubMed ID: 8617420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can red cell distribution width help to discriminate benign from malignant biliary obstruction? A retrospective single center analysis.
    Beyazit Y; Kekilli M; Ibis M; Kurt M; Sayilir A; Onal IK; Purnak T; Oztas E; Tas A; Yesil Y; Arhan M
    Hepatogastroenterology; 2012; 59(117):1469-73. PubMed ID: 22683963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement.
    Yang XQ; Yan L; Chen C; Hou JX; Li Y
    Hepatogastroenterology; 2009; 56(94-95):1388-94. PubMed ID: 19950797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1992; 12(5):1687-93. PubMed ID: 1332581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [CA19-9 has no value as a tumor marker in obstructive jaundice].
    Peterli R; Meyer-Wyss B; Herzog U; Tondelli P
    Schweiz Med Wochenschr; 1999 Jan; 129(3):77-9. PubMed ID: 10065510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.